Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Product

Inactivated SARS-CoV-2 Vaccine

Aliases
CoronaVac, Inactivated SARS-CoV-2 Vaccine (Vero cell), Low dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 28-day schedule

5 clinical trials

1 indication

Indication
COVID-19
Clinical trial
A Randomized, Double-Blinded, Placebo-Controlled, Phase Ⅰ/Ⅱ Clinical Trial, to Evaluate the Safety and Immunogenicity of the SARS-CoV-2 Inactivated Vaccine (Vero Cell) in Healthy Population Aged 3-17 Years
Status: Completed, Estimated PCD: 2021-04-30
Clinical trial
Multicenter, Randomized, Double Blind, Parallel Placebo Controlled, Phase III Clinical Trial to Evaluate the Protective Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) in Healthy Population Aged 18 Years Old and Above
Status: Completed, Estimated PCD: 2021-06-16
Clinical trial
A Double-blind, Randomized Clinical Trial to Evaluate the Lot-to-lot Consistency, Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine (CoronaVac）Between Different Workshops for Prevention of COVID-19 in Healthy Children Aged 3-17 Years
Status: Active (not recruiting), Estimated PCD: 2021-11-19
Clinical trial
A Randomized, Double-blind, Placebo-controlled, Phase Ia/IIa Trial of an Inactivated SARS-CoV-2 Vaccine in Healthy People Aged 18 to 59 Years
Status: Completed, Estimated PCD: 2020-08-10
Clinical trial
A Randomized, Double-blind, Placebo-controlled, Phase Ib/IIb Trial of an Inactivated SARS-CoV-2 Vaccine in Healthy People Aged ⩾60 Years
Status: Completed, Estimated PCD: 2020-10-30